Stepped wedged cluster randomized control trial from the World Health Organization comparing outcomes in those who received a Checklist. Implementation of the WHO Surgical Safey Checklist decreased morbidty and hospital length of stay.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic
May 3, 2014
This systematic review and meta-analysis of individual patient data from 15 RCTs (2385 pts) assessed the utility of preoperative chemotherapy in patients with primarily stages Ib-IIIa NSCLC. Chemotherapy resulted in a 13% reduction in death (HR 0.87, p=0.007), and a 5% survival improvement at 5 years.
May 1, 2014
A panel for the Centers for Medicare and Medicaid determined that annual low-dose CT screening for lung cancer carries too high a risk related to the potential benefits. They expressed concern about high false-positive rates, quality assurance, and gaps in evidence as to how the CT results would be used. Despite the fact that many professional grou
April 10, 2014
This is an outstanding 20 minute video on all aspects of segmentectomy for lung cancer from one of the world's experts.
There is a whole free Journal on this issue which can be found at http://www.annalscts.com/issue/view/37
March 27, 2014
A consensus statement on video-assisted thoracoscopic lobectomy for patients with non-small-cell lung cancer has been issued by 50 international experts.
March 7, 2014
LVI is thought to be an adverse prognostic indicator of survival in patients with NSCLC. This review quantified the relationship of LVI and survival. The unadjusted effect of LVI for recurrence-free survival was HR=3.63 and for overall survival was HR=2.38. After adjustment for covarates, these HRs were 2.52 and 1.81, both highly significant.
December 17, 2013
Filmed at the 2013 EACTS Annual Meeting, this roundtable discussion focuses on Video Assisted Thoracoscopic Surgery (VATS), specifically VATS Lobectomy. Joel Dunning, FRCS, PhD moderates this discussion with Marco Scarci, MD, FRCS, and Peyman Sardari Nia, PhD.
February 24, 2013
This survey was completed by over 300 participants, which is the largest participation level we have seen for such surveys. This may indicate the general interest level in assessment of the high risk patient for lung resection.
January 7, 2013
Dr. Joel Dunning leads a discussion on VATS and robotic lobectomy, sleeve lobectomy and pneumonectomy, new devices, as well as many other related issues.
November 14, 2012
For purposes of this survey, readers were asked to assume that they consulted on an otherwise healthy middle aged patient with a distal esophageal adenocarcinoma, T1bN0 by EUS. There were no contraindications to esophagectomy.